CN106916154A - 一种尺寸可调的苝酰亚胺类多功能纳米颗粒及其制备与应用 - Google Patents
一种尺寸可调的苝酰亚胺类多功能纳米颗粒及其制备与应用 Download PDFInfo
- Publication number
- CN106916154A CN106916154A CN201710158228.7A CN201710158228A CN106916154A CN 106916154 A CN106916154 A CN 106916154A CN 201710158228 A CN201710158228 A CN 201710158228A CN 106916154 A CN106916154 A CN 106916154A
- Authority
- CN
- China
- Prior art keywords
- nano
- perylene diimide
- amino
- perylene
- suo shu
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002105 nanoparticle Substances 0.000 title claims abstract description 75
- KJOLVZJFMDVPGB-UHFFFAOYSA-N perylenediimide Chemical class C=12C3=CC=C(C(NC4=O)=O)C2=C4C=CC=1C1=CC=C2C(=O)NC(=O)C4=CC=C3C1=C42 KJOLVZJFMDVPGB-UHFFFAOYSA-N 0.000 title claims abstract description 32
- 238000002360 preparation method Methods 0.000 title description 6
- CSHWQDPOILHKBI-UHFFFAOYSA-N peryrene Natural products C1=CC(C2=CC=CC=3C2=C2C=CC=3)=C3C2=CC=CC3=C1 CSHWQDPOILHKBI-UHFFFAOYSA-N 0.000 claims abstract description 29
- 125000002080 perylenyl group Chemical group C1(=CC=C2C=CC=C3C4=CC=CC5=CC=CC(C1=C23)=C45)* 0.000 claims abstract description 28
- -1 perylene diimide class compound Chemical class 0.000 claims abstract description 24
- 229920001223 polyethylene glycol Polymers 0.000 claims abstract description 20
- 239000002202 Polyethylene glycol Substances 0.000 claims abstract description 18
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims abstract description 14
- 238000000034 method Methods 0.000 claims abstract description 10
- 230000004048 modification Effects 0.000 claims abstract description 9
- 238000012986 modification Methods 0.000 claims abstract description 9
- 239000003153 chemical reaction reagent Substances 0.000 claims abstract description 8
- FPYJFEHAWHCUMM-UHFFFAOYSA-N maleic anhydride Chemical compound O=C1OC(=O)C=C1 FPYJFEHAWHCUMM-UHFFFAOYSA-N 0.000 claims abstract description 8
- TZRXHJWUDPFEEY-UHFFFAOYSA-N Pentaerythritol Tetranitrate Chemical compound [O-][N+](=O)OCC(CO[N+]([O-])=O)(CO[N+]([O-])=O)CO[N+]([O-])=O TZRXHJWUDPFEEY-UHFFFAOYSA-N 0.000 claims abstract description 7
- 239000003814 drug Substances 0.000 claims abstract description 7
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims abstract description 7
- 238000001338 self-assembly Methods 0.000 claims abstract description 4
- 150000001875 compounds Chemical class 0.000 claims description 12
- 125000000217 alkyl group Chemical group 0.000 claims description 8
- 239000002872 contrast media Substances 0.000 claims description 6
- 238000007626 photothermal therapy Methods 0.000 claims description 6
- 150000003973 alkyl amines Chemical class 0.000 claims description 5
- 125000000524 functional group Chemical group 0.000 claims description 5
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 4
- 150000008065 acid anhydrides Chemical class 0.000 claims description 4
- 150000001412 amines Chemical class 0.000 claims description 4
- 229910052799 carbon Inorganic materials 0.000 claims description 4
- 229920001427 mPEG Polymers 0.000 claims description 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 4
- 150000003235 pyrrolidines Chemical class 0.000 claims description 4
- SIWITHKVJAGPAM-UHFFFAOYSA-N [Br].C1=CC(C2=CC=CC=3C2=C2C=CC=3)=C3C2=CC=CC3=C1 Chemical group [Br].C1=CC(C2=CC=CC=3C2=C2C=CC=3)=C3C2=CC=CC3=C1 SIWITHKVJAGPAM-UHFFFAOYSA-N 0.000 claims description 3
- 239000002253 acid Substances 0.000 claims description 3
- 230000008685 targeting Effects 0.000 claims description 3
- 125000001246 bromo group Chemical group Br* 0.000 claims description 2
- 239000011258 core-shell material Substances 0.000 claims description 2
- 229940068917 polyethylene glycols Drugs 0.000 claims description 2
- 230000002285 radioactive effect Effects 0.000 claims description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N ethylene glycol Natural products OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims 4
- 150000001408 amides Chemical class 0.000 claims 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 claims 1
- 238000003384 imaging method Methods 0.000 abstract description 22
- 206010028980 Neoplasm Diseases 0.000 abstract description 4
- 230000000694 effects Effects 0.000 abstract description 4
- 230000003902 lesion Effects 0.000 abstract description 4
- 208000007536 Thrombosis Diseases 0.000 abstract description 3
- 206010061218 Inflammation Diseases 0.000 abstract description 2
- 230000004054 inflammatory process Effects 0.000 abstract description 2
- 210000004324 lymphatic system Anatomy 0.000 abstract description 2
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 abstract description 2
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 12
- 238000010521 absorption reaction Methods 0.000 description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
- 238000006243 chemical reaction Methods 0.000 description 10
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 8
- 239000002245 particle Substances 0.000 description 8
- 230000002776 aggregation Effects 0.000 description 7
- 238000004220 aggregation Methods 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 6
- 125000003368 amide group Chemical group 0.000 description 6
- 230000015572 biosynthetic process Effects 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 238000003786 synthesis reaction Methods 0.000 description 6
- WDLRUFUQRNWCPK-UHFFFAOYSA-N Tetraxetan Chemical compound OC(=O)CN1CCN(CC(O)=O)CCN(CC(O)=O)CCN(CC(O)=O)CC1 WDLRUFUQRNWCPK-UHFFFAOYSA-N 0.000 description 5
- 238000011160 research Methods 0.000 description 5
- 238000001228 spectrum Methods 0.000 description 5
- 239000012043 crude product Substances 0.000 description 4
- 238000000799 fluorescence microscopy Methods 0.000 description 4
- 210000001165 lymph node Anatomy 0.000 description 4
- 229910052757 nitrogen Inorganic materials 0.000 description 4
- 238000005160 1H NMR spectroscopy Methods 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 238000013461 design Methods 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 239000003480 eluent Substances 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 239000012071 phase Substances 0.000 description 3
- 239000000741 silica gel Substances 0.000 description 3
- 229910002027 silica gel Inorganic materials 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 238000010189 synthetic method Methods 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- 241000209094 Oryza Species 0.000 description 2
- 235000007164 Oryza sativa Nutrition 0.000 description 2
- 150000001335 aliphatic alkanes Chemical class 0.000 description 2
- 235000013339 cereals Nutrition 0.000 description 2
- 230000002490 cerebral effect Effects 0.000 description 2
- QEWYKACRFQMRMB-UHFFFAOYSA-N fluoroacetic acid Chemical compound OC(=O)CF QEWYKACRFQMRMB-UHFFFAOYSA-N 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 230000000302 ischemic effect Effects 0.000 description 2
- 150000002979 perylenes Chemical class 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 238000002601 radiography Methods 0.000 description 2
- 235000009566 rice Nutrition 0.000 description 2
- 239000004065 semiconductor Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical class CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 1
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 1
- 208000011338 SATB2 associated disease Diseases 0.000 description 1
- 208000013959 SATB2-associated syndrome Diseases 0.000 description 1
- 238000000862 absorption spectrum Methods 0.000 description 1
- ZOIORXHNWRGPMV-UHFFFAOYSA-N acetic acid;zinc Chemical compound [Zn].CC(O)=O.CC(O)=O ZOIORXHNWRGPMV-UHFFFAOYSA-N 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 238000011938 amidation process Methods 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000011260 aqueous acid Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 238000000149 argon plasma sintering Methods 0.000 description 1
- 125000000852 azido group Chemical group *N=[N+]=[N-] 0.000 description 1
- 231100000693 bioaccumulation Toxicity 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 239000000090 biomarker Substances 0.000 description 1
- 238000001574 biopsy Methods 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 239000013522 chelant Substances 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000003759 clinical diagnosis Methods 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 238000010511 deprotection reaction Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 125000000950 dibromo group Chemical group Br* 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 238000002296 dynamic light scattering Methods 0.000 description 1
- 150000002118 epoxides Chemical class 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 150000002460 imidazoles Chemical class 0.000 description 1
- 125000005462 imide group Chemical group 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 239000002071 nanotube Substances 0.000 description 1
- 125000004433 nitrogen atom Chemical group N* 0.000 description 1
- 238000010606 normalization Methods 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920000128 polypyrrole Polymers 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 150000003233 pyrroles Chemical class 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 235000011127 sodium aluminium sulphate Nutrition 0.000 description 1
- 238000001808 supercritical antisolvent technique Methods 0.000 description 1
- 238000002626 targeted therapy Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000002371 ultraviolet--visible spectrum Methods 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
- 230000010148 water-pollination Effects 0.000 description 1
- 239000004246 zinc acetate Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0052—Thermotherapy; Hyperthermia; Magnetic induction; Induction heating therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/22—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations
- A61K49/222—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations characterised by a special physical form, e.g. emulsions, liposomes
- A61K49/225—Microparticles, microcapsules
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y20/00—Nanooptics, e.g. quantum optics or photonic crystals
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y30/00—Nanotechnology for materials or surface science, e.g. nanocomposites
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K11/00—Luminescent, e.g. electroluminescent, chemiluminescent materials
- C09K11/06—Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1018—Heterocyclic compounds
- C09K2211/1025—Heterocyclic compounds characterised by ligands
- C09K2211/1029—Heterocyclic compounds characterised by ligands containing one nitrogen atom as the heteroatom
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nanotechnology (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Physics & Mathematics (AREA)
- Crystallography & Structural Chemistry (AREA)
- Public Health (AREA)
- Materials Engineering (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Radiology & Medical Imaging (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Acoustics & Sound (AREA)
- Composite Materials (AREA)
- Condensed Matter Physics & Semiconductors (AREA)
- General Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Biophysics (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710158228.7A CN106916154A (zh) | 2017-03-16 | 2017-03-16 | 一种尺寸可调的苝酰亚胺类多功能纳米颗粒及其制备与应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710158228.7A CN106916154A (zh) | 2017-03-16 | 2017-03-16 | 一种尺寸可调的苝酰亚胺类多功能纳米颗粒及其制备与应用 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106916154A true CN106916154A (zh) | 2017-07-04 |
Family
ID=59461492
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710158228.7A Pending CN106916154A (zh) | 2017-03-16 | 2017-03-16 | 一种尺寸可调的苝酰亚胺类多功能纳米颗粒及其制备与应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106916154A (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111569074A (zh) * | 2020-06-18 | 2020-08-25 | 吉林大学 | 一种兼具选择性及光热抗菌性能的纳米片层、制备方法及其应用 |
CN112391047A (zh) * | 2019-08-14 | 2021-02-23 | 湖南科技大学 | 一种温度刺激响应性苝二酰亚胺超分子荧光凝胶及制备方法与应用 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103570714A (zh) * | 2012-07-30 | 2014-02-12 | 北京印刷学院 | 一种合成子及利用合成子制备二苯并蔻类化合物的方法 |
CN103570713A (zh) * | 2012-07-20 | 2014-02-12 | 宁波大学 | 一种可聚合苝酰亚胺类光电受体材料及其合成方法 |
CN104804196A (zh) * | 2015-04-09 | 2015-07-29 | 南京邮电大学 | 一种光声成像聚合物与磁纳米复合材料及制备方法 |
CN104946241A (zh) * | 2015-06-04 | 2015-09-30 | 中国科学院化学研究所 | 一维有机半导体纳米管及其制备方法和应用 |
-
2017
- 2017-03-16 CN CN201710158228.7A patent/CN106916154A/zh active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103570713A (zh) * | 2012-07-20 | 2014-02-12 | 宁波大学 | 一种可聚合苝酰亚胺类光电受体材料及其合成方法 |
CN103570714A (zh) * | 2012-07-30 | 2014-02-12 | 北京印刷学院 | 一种合成子及利用合成子制备二苯并蔻类化合物的方法 |
CN104804196A (zh) * | 2015-04-09 | 2015-07-29 | 南京邮电大学 | 一种光声成像聚合物与磁纳米复合材料及制备方法 |
CN104946241A (zh) * | 2015-06-04 | 2015-09-30 | 中国科学院化学研究所 | 一维有机半导体纳米管及其制备方法和应用 |
Non-Patent Citations (1)
Title |
---|
CAO CUI等: "《Organic Semiconducting Nanoparticles as Efficient Photoacoustic Agents for Lightening Early Thrombus and Monitoring Thrombolysis in Living Mice》", 《AMERICAN CHEMICAL SOCIETY》 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112391047A (zh) * | 2019-08-14 | 2021-02-23 | 湖南科技大学 | 一种温度刺激响应性苝二酰亚胺超分子荧光凝胶及制备方法与应用 |
CN112391047B (zh) * | 2019-08-14 | 2023-02-21 | 湖南科技大学 | 一种温度刺激响应性苝二酰亚胺超分子荧光凝胶及制备方法与应用 |
CN111569074A (zh) * | 2020-06-18 | 2020-08-25 | 吉林大学 | 一种兼具选择性及光热抗菌性能的纳米片层、制备方法及其应用 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Jiang et al. | Facile construction and biological imaging of cross-linked fluorescent organic nanoparticles with aggregation-induced emission feature through a catalyst-free azide-alkyne click reaction | |
CN112566911B (zh) | 光热试剂 | |
Wang et al. | Fluorine and Nitrogen Co-Doped Carbon Dot Complexation with Fe (III) as a T 1 Contrast Agent for Magnetic Resonance Imaging | |
CN110128665B (zh) | 基于偶氮还原酶响应的两亲性嵌段聚合物近红外荧光探针及应用 | |
CN108524449B (zh) | 一种负载药体的近红外染料功能化的智能超分子囊泡 | |
WO2018210206A1 (en) | Theranostic agents | |
Xu et al. | Highly stable organic photothermal agent based on near-infrared-II fluorophores for tumor treatment | |
CN109464677B (zh) | 一种用于肿瘤靶向诊疗的近红外光控纳米颗粒及制备方法 | |
WO2020182174A1 (en) | Aie compounds with fluorescence, photoacoustic, and raman properties | |
Huang et al. | Color‐Convertible, Unimolecular, Micelle‐Based, Activatable Fluorescent Probe for Tumor‐Specific Detection and Imaging In Vitro and In Vivo | |
CN106916154A (zh) | 一种尺寸可调的苝酰亚胺类多功能纳米颗粒及其制备与应用 | |
KR101643295B1 (ko) | 폴리실세스퀴옥산을 코어로 하는 수용성 포르피린집합체 광감작제 및 그 제조방법 | |
Li et al. | Triphenylamine flanked boron difluoride formazanate for NIR-II fluorescence imaging-guided photothermal therapy | |
CN117800951A (zh) | 一种近红外荧光探针及其制备方法与应用 | |
CN113717089A (zh) | 一种氟化Cy7化合物及其合成方法和应用 | |
CN113444089A (zh) | 基于苝二酰亚胺衍生物的近红外二区聚集诱导发光分子及其制备方法和应用 | |
CN111039853B (zh) | 一种可用于光声成像和光热治疗的铁配合物及其制备方法和用途 | |
Luo et al. | Synthesis of fluorescent dendrimers with aggregation-induced emission features through a one-pot multi-component reaction and their utilization for biological imaging | |
CN106674315A (zh) | 基于季戊四醇的Janus脂质及其中间体,制备方法与用途 | |
CN111693495B (zh) | 一种近红外双通道荧光活体显微成像方法 | |
Günsel et al. | 3-Chloro-4-fluorophenoxy substituted zinc phthalocyanine/graphene oxide composites: exploring of their sono-photochemical properties | |
CN114230596B (zh) | 一类具有大于1200nm吸收的乙烯桥联氟硼吡咯聚集体的制备方法及其光热诊疗应用 | |
Wang et al. | A bimodal MRI and NIR liposome nanoprobe for tumor targeted molecular imaging | |
CN109678993A (zh) | 一种可逆乏氧-常氧循环检测的内标比率型纳米荧光探针、制备方法及其应用 | |
Sajjad et al. | Synthesis and in vitro PDT evaluation of red emission polymer dots (R-CPDs) and pyropheophorbide-α conjugates |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information |
Inventor after: Lu Guangming Inventor after: Yang Zhen Inventor after: Chen Xiaoyuan Inventor after: Fan Quli Inventor after: Song Jibin Inventor before: Yang Zhen Inventor before: Chen Xiaoyuan Inventor before: Fan Quli Inventor before: Song Jibin |
|
CB03 | Change of inventor or designer information | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20170816 Address after: 210002 Zhongshan East Road, Xuanwu District, Jiangsu, No. 305, No. Applicant after: Nanjing General Hospital of Nanjing Millitary Area Command, P. L. A. Address before: Nanjing City, Jiangsu province 210003 Yuen Road No. 9 Applicant before: Nanjing Post & Telecommunication Univ. |
|
TA01 | Transfer of patent application right | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170704 |
|
RJ01 | Rejection of invention patent application after publication |